447 related articles for article (PubMed ID: 22497677)
21. Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD.
Guenette JA; Raghavan N; Harris-McAllister V; Preston ME; Webb KA; O'Donnell DE
Respir Med; 2011 Dec; 105(12):1836-45. PubMed ID: 21917440
[TBL] [Abstract][Full Text] [Related]
22. Inspiratory fraction correlates with exercise capacity in patients with stable moderate to severe COPD.
Zhang Y; Sun XG; Yang WL; Tan XY; Liu JM
Respir Care; 2013 Nov; 58(11):1923-30. PubMed ID: 23592787
[TBL] [Abstract][Full Text] [Related]
23. Effect of indacaterol on exercise endurance and lung hyperinflation in COPD.
O'Donnell DE; Casaburi R; Vincken W; Puente-Maestu L; Swales J; Lawrence D; Kramer B;
Respir Med; 2011 Jul; 105(7):1030-6. PubMed ID: 21498063
[TBL] [Abstract][Full Text] [Related]
24. A better response in exercise capacity after pulmonary rehabilitation in more severe COPD patients.
Altenburg WA; de Greef MH; ten Hacken NH; Wempe JB
Respir Med; 2012 May; 106(5):694-700. PubMed ID: 22154126
[TBL] [Abstract][Full Text] [Related]
25. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
[TBL] [Abstract][Full Text] [Related]
26. Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD.
Berton DC; Reis M; Siqueira AC; Barroco AC; Takara LS; Bravo DM; Andreoni S; Neder JA
Respir Med; 2010 Sep; 104(9):1288-96. PubMed ID: 20580216
[TBL] [Abstract][Full Text] [Related]
27. Effect of fluticasone/salmeterol combination on dyspnea and respiratory mechanics in mild-to-moderate COPD.
Guenette JA; Webb KA; O'Donnell DE
Respir Med; 2013 May; 107(5):708-16. PubMed ID: 23421968
[TBL] [Abstract][Full Text] [Related]
28. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
[TBL] [Abstract][Full Text] [Related]
29. Endurance shuttle walking test: responsiveness to salmeterol in COPD.
Brouillard C; Pepin V; Milot J; Lacasse Y; Maltais F
Eur Respir J; 2008 Mar; 31(3):579-84. PubMed ID: 18057052
[TBL] [Abstract][Full Text] [Related]
30. Physiological effects of roflumilast at rest and during exercise in COPD.
O'Donnell DE; Bredenbröker D; Brose M; Webb KA
Eur Respir J; 2012 May; 39(5):1104-12. PubMed ID: 21965226
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
32. Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease.
Gagnon P; Bussières JS; Ribeiro F; Gagnon SL; Saey D; Gagné N; Provencher S; Maltais F
Am J Respir Crit Care Med; 2012 Oct; 186(7):606-15. PubMed ID: 22822019
[TBL] [Abstract][Full Text] [Related]
33. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease.
Saey D; Debigare R; LeBlanc P; Mador MJ; Cote CH; Jobin J; Maltais F
Am J Respir Crit Care Med; 2003 Aug; 168(4):425-30. PubMed ID: 12714348
[TBL] [Abstract][Full Text] [Related]
34. [Cardiac autonomic responses to exercise testing in patients with chronic obstructive pulmonary disease].
Inal Ince D; Savci S; Arikan H; Sağlam M; Boşnak Güçlü M; Tokgözoğlu L; Cöplü L
Anadolu Kardiyol Derg; 2010 Apr; 10(2):104-10. PubMed ID: 20382606
[TBL] [Abstract][Full Text] [Related]
35. Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study.
Majewski S; Slomka S; Zielinska-Wyderkiewicz E; Ciebiada M; Gorski P
Am J Cardiovasc Drugs; 2012 Jun; 12(3):179-88. PubMed ID: 22409211
[TBL] [Abstract][Full Text] [Related]
36. Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD.
Peters MM; Webb KA; O'Donnell DE
Thorax; 2006 Jul; 61(7):559-67. PubMed ID: 16467067
[TBL] [Abstract][Full Text] [Related]
37. Bronchodilators accelerate the dynamics of muscle O2 delivery and utilisation during exercise in COPD.
Berton DC; Barbosa PB; Takara LS; Chiappa GR; Siqueira AC; Bravo DM; Ferreira LF; Neder JA
Thorax; 2010 Jul; 65(7):588-93. PubMed ID: 20627914
[TBL] [Abstract][Full Text] [Related]
38. Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease.
Pepin V; Saey D; Whittom F; LeBlanc P; Maltais F
Am J Respir Crit Care Med; 2005 Dec; 172(12):1517-22. PubMed ID: 16166613
[TBL] [Abstract][Full Text] [Related]
39. Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD.
Vogiatzis I; Nanas S; Kastanakis E; Georgiadou O; Papazahou O; Roussos Ch
Eur Respir J; 2004 Sep; 24(3):385-90. PubMed ID: 15358696
[TBL] [Abstract][Full Text] [Related]
40. Pursed lip breathing improves exercise tolerance in COPD: a randomized crossover study.
Cabral LF; D'Elia Tda C; Marins Dde S; Zin WA; Guimarães FS
Eur J Phys Rehabil Med; 2015 Feb; 51(1):79-88. PubMed ID: 24691248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]